Two weeks ago, Michelle Lott represented interests of small manufacturers at the Arizona BioIndustry Association (AZBio) Expo panel on “Getting Innovation to the Finish Line: Regulatory Perspective in the era of 21st Century Cures“. During this panel, Michelle Lott discussed how recent policies and FDA negotiations with Congress are impacting industry’s path and cost to market. Be sure to watch the AZBio Expo YouTube video to learn how you will be impacted. Thanks to everyone who came by!
We would love to hear your thoughts, comments and feedback.